Experimental Models of Virus-Induced Demyelination

Myelin Biology and Disorders

Volumn 2, Issue , 2004, Pages 1073-1100

  Bieber, A J ^a   Rodriguez, M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58349113799     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50097-8     Document Type: Chapter

References (153)

1. Adami C., Pritchard A.E., Knauf T., Luo M., Lipton H.L. A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J. Virol. 1998, 72:1662-1665.
2. Altintas A., Cai Z., Pease L.R., Rodriguez M. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J. Immunol. 1993, 151:2803-2812.
3. Asakura K., Miller D.J., Pease L.R., Rodriguez M. Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination. J. Neurosci. 1998, 18:7700-7708.
4. Aubagnac S., Brahic M., Bureau J.F. Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J. Virol. 1999, 73:7965-7971.
5. Aubert C., Chamorro M., Brahic M. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog. 1987, 3:319-326.
6. Azoulay A., Brahic M., Bureau J.F. FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. J. Virol. 1994, 68:4049-4052.
7. Barac-Latas V., Suchanek G., Breitschopf H., Stuehler A., Wege H., Lassmann H. Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 1997, 19:1-12.
8. Barbano R.L., Dal Canto M.C. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE. J. Neurol. Sci. 1984, 66:283-293.
9. Begolka W.S., Haynes L.M., Olson J.K., Padilla J., Neville K.L., Dal Canto M., Palma J., Kim B.S., Miller S.D. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J. Neurovirol. 2001, 7:409-420.
10. + T cells during viral persistence in the central nervous system. J. Immunol. 1999, 163:3379-3387.
11. Bihl F., Brahic M., Bureau J.F. Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice. Genetics 1999, 152:385-392.
12. Bihl F., Pena-Rossi C., Guenet J.L., Brahic M., Bureau J.F. The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J. Virol. 1997, 71:5025-5030.
13. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 1997, 71:5244-5250.
14. Brahic M., Stroop W.G., Baringer J.R. Theiler's virus persists in glial cells during demyelinating disease. Cell 1981, 26:123-128.
15. Bureau J.F., Drescher K.M., Pease L.R., Vikoren T., Delcroix M., Zoecklein L., Brahic M., Rodriguez M. Chromosome 14 contains determinants that regulate susceptibility to Theiler's virus-induced demyelination in the mouse. Genetics 1998, 148:1941-1949.
16. Bureau J.F., Montagutelli X., Bihl F., Lefebvre S., Guenet J.L., Brahic M. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 1993, 5:87-91.
17. Cardin A.D., Weintraub H.J. Molecular modelling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32.
18. Cheever F.S., Daniels J.B., Pappenheimer A.M., Bailey O.T. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J. Exp. Med. 1948, 90:181-194.
19. Chen H.H., Kong W.P., Zhang L., Ward P.L., Roos R.P. A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat. Med. 1995, 1:927-931.
20. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: Correlation with clinical signs. J. Immunol. 1986, 136:920-927.
21. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: Correlation with TEMV-specific delayed-type hypersensitivity. J Immunol. 1985, 135:1408-1414.
22. Clatch R.J., Miller S.D., Metzner R., Dal Canto M.C., Lipton H.L. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 1990, 176:244-254.
23. Dal Canto M.C., Lipton H.L. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest. 1975, 33:626-637.
24. Dandekar A.A., Wu G.F., Pewe L., Perlman S. Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J. Virol. 2001, 75:6115-6120.
25. Daniels J.B., Pappenheimer A.M., Richardson S. Observations on Encephalitis of Mice. J. Exp. Med. 1952, 96:517.
26. Dethlefs S., Escriou N., Brahic M., van der Werf S., Larsson-Sciard E.L. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 1997, 71:5361-5365.
27. Drescher K.M., Rivera-Quinones C., Lucchinetti C.F., Rodriguez M. Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple slcerosis. J. Neuroimmunol. 1998, 88:111-119.
28. Erlich S.S., Fleming J.O., Stohlman S.A., Weiner L.P. Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch. Neurol. 1987, 44:839-842.
29. Fiette L., Aubert C., Brahic M., Rossi C.P. Theiler's virus infection of beta 2-microglobulin-deficient mice. J. Virol. 1993, 67:589-592.
30. Fleming J.O., Trousdale M.D., el-Zaatari F.A., Stohlman S.A., Weiner L.P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 1986, 58:869-875.
31. Fotiadis C., Kilpatrick D.R., Lipton H.L. Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology 1991, 182:365-370.
32. Fu J., Rodriguez M., Roos R.P. Strains from both Theiler's virus subgroups encode a determinant for demyelination. J. Virol. 1990, 64:6345-6348.
33. Fu J.L., Stein S., Rosenstein L., Bodwell T., Routbort M., Semler B.L., Roos R.P. Neurovirulence determinants of genetically engineered Theiler viruses. Proc. Natl. Acad. Sci. USA 1990, 87:4125-4129.
34. Ghadge G.D., Ma L., Sato S., Kim J., Roos R.P. A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J. Virol. 1998, 72:8605-8612.
35. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 1994, 152:919-929.
36. Grant R.A., Filman D.J., Fujinami R.S., Icenogle J.P., Hogle J.M. Three-dimensional structure of Theiler virus. Proc. Natl. Acad. Sci. USA 1992, 89:2061-2065.
37. Graves M.C., Bologa L., Siegel L., Londe H. Theiler's virus in brain cell cultures: Lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. J. Neurosci. Res. 1986, 15:491-501.
38. Haspel M.V., Lampert P.W., Oldstone M.B. Temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. USA 1978, 75:4033-4036.
39. Hertzler S., Luo M., Lipton H.L. Mutation of predicted virion pit residues alters binding of Theiler's murine encephalomyelitis virus to BHK-21 cells. J. Virol. 2000, 74:1994-2004.
40. Houtman J.J., Fleming J.O. Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J. Neurovirol. 1996, 2:101-110.
41. Jakob J., Roos R.P. Molecular determinants of Theiler's murine encephalomyelitis-induced disease. J. Neurovirol. 1996, 2:70-77.
42. Jelachich M.L., Bandyopadhyay P., Blum K., Lipton H.L. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 1995, 209:437-444.
43. Jnaoui K., Minet M., Michiels T. Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity. J. Virol. 2002, 76:8138-8147.
44. 121 130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 1999, 73:3702-3708.
45. + virus peptide-specific T cells in Theiler's virus infection. FASEB J. 2001, 15:2760-2762.
46. Kappel C.A., Melvold R.W., Kim B.S. Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J. Neuroimmunol. 1990, 29:15-19.
47. Karpus W.J., Pope J.G., Peterson J.D., Dal Canto M.C., Miller S.D. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 1995, 155:947-957.
48. Lane T.E., Liu M.T., Chen B.P., Asensio V.C., Samawi R.M., Paoletti A.D., Campbell I.L., Kunkel S.L., Fox H.S., Buchmeier M.J. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J. Virol. 2000, 74:1415-1424.
49. Lavi E., Gilden D.H., Highkin M.K., Weiss S.R. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J. Virol. 1984, 51:563-566.
50. Lehmann P.V., Sercarz E.E., Forsthuber T., Dayan C.M., Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 1993, 14:203-208.
51. Lehrich J.R., Arnason B.G., Hochberg F.H. Demyelinative myelopathy in mice induced by the DA virus. J. Neurol. Sci. 1976, 29:149-160.
52. Levy M., Aubert C., Brahic M. Theiler's virus replication in brain macrophages cultured in vitro. J. Virol. 1992, 66:3188-3193.
53. Lin M.T., Hinton D.R., Marten N.W., Bergmann C.C., Stohlman S.A. Antibody prevents virus reactivation within the central nervous system. J Immunol. 1999, 162:7358-7368.
54. Lin M.T., Stohlman S.A., Hinton D.R. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 1997, 71:383-391.
55. Lin X., Pease L.R., Rodriguez M. Differential generation of class I H-2D-versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection. Eur. J. Immunol. 1997, 27:963-970.
56. Lin X., Sato S., Patick A.K., Pease L.R., Roos R.P., Rodriguez M. Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line. J. Virol. 1998, 72:1262-1269.
57. Lindsley M.D., Patick A.K., Prayoonwiwat N., Rodriguez M. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: A model for multiple sclerosis. Mayo Clin. Proc. 1992, 67:829-838.
58. Lindsley M.D., Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 1989, 142:2677-2682.
59. Lipton H.L. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect. Immun. 1975, 11:1147-1155.
60. Lipton H.L. Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses. Infect. Immun. 1978, 20:869-872.
61. Lipton H.L., Calenoff M., Bandyopadhyay P., Miller S.D., Dal Canto M.C., Gerety S., Jensen K. The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J. Virol. 1991, 65:4370-4377.
62. Lipton H.L., Dal Canto M.C. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 1976, 30:201-207.
63. Lipton H.L., Dal Canto M.C. Theiler's virus-induced demyelination: Prevention by immunosuppression. Science 1976, 192:62-64.
64. Lipton H.L., Dal Canto M.C. Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect. Immun. 1979, 26:369-374.
65. Lipton H.L., Melvold R. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 1984, 132:1821-1825.
66. Lipton H.L., Pritchard A.E., Calenoff M.A. Attenuation of neurovirulence of Theiler's murine encephalomyelitis virus strain GDVII is not sufficient to establish persistence in the central nervous system. J. Gen. Virol. 1998, 79:1001-1004.
67. Lipton H.L., Twaddle G., Jelachich M.L. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 1995, 69:2525-2533.
68. Lorch Y., Friedmann A., Lipton H.L., Kotler M. Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J. Virol. 1981, 40:560-567.
69. Lucchinetti C.F., Rodriguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin. Proc. 1997, 72:665-678.
70. Ludwin S.K., Johnson E.S. Evidence for a "dying-back" gliopathy in demyelinating disease. Ann. Neurol. 1981, 9:301-305.
71. Luo M., He C., Toth K.S., Zhang C.X., Lipton H.L. Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc. Natl. Acad. Sci. USA 1992, 89:2409-2413.
72. Luo M., Toth K.S., Zhou L., Pritchard A., Lipton H.L. The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology 1996, 220:246-250.
73. Matthews A.E., Lavi E., Weiss S.R., Paterson Y. Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J. Neurovirol. 2002, 8:257-264.
74. McGavern D.B., Murray P.D., Rivera-Quinones C., Schmelzer J.D., Low P.A., Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain 2000, 123:519-531.
75. McGavern D.B., Zoecklein L., Drescher K.M., Rodriguez M. Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp. Neurol. 1999, 158:171-181.
76. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 1995, 182:75-85.
77. Melvold R.W., Jokinen D.M., Miller S.D., Dal Canto M.C., Lipton H.L. Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 1990, 64:686-690.
78. Miller D.J., Asakura K., Rodriguez M. Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol. 1996, 6:331-344.
79. Miller D.J., Rivera-Quinones C., Njenga M.K., Leibowitz J., Rodriguez M. Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination. J. Neurosci. 1995, 15:8345-8352.
80. Miller S.D., Gerety S.J., Kennedy M.K., Peterson J.D., Trotter J.L., Tuohy V.K., Waltenbaugh C., Dal Canto M.C., Lipton H.L. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J. Neuroimmunol. 1990, 26:9-23.
81. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
82. Murray P.D., McGavern D.B., Sathornsumetee S., Rodriguez M. Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis. Brain 2001, 124:1403-1416.
83. Murray P.D., Pavelko K.D., Leibowitz J., Lin X., Rodriguez M. CD4(+) and Cd8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 1998, 72:7320-7329.
84. Neville K.L., Padilla J., Miller S.D. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: Implications for the treatment of MS. J. Neuroimmunol. 2002, 123:18-29.
85. Nitayaphan S., Omilianowski D., Toth M.M., Parks G.D., Rueckert R.R., Palmenberg A.C., Roos R.P. Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology 1986, 26:140-148.
86. Njenga M.K., Asakura K., Hunter S.F., Wettstein P., Pease L.R., Rodriguez M. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 1997, 71:8592-8601.
87. Njenga M.K., Coenen M.J., DeCuir N., Yeh H.Y., Rodriguez M. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. J. Neurosci. Res. 2000, 59:661-670.
88. Njenga M.K., Murray P.D., McGavern D., Lin X., Drescher K.M., Rodriguez M. Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. J. Neuropathol. Exp. Neurol. 1999, 58:78-91.
89. Njenga M.K., Pavelko K.D., Baisch J., Lin X., David C., Leibowitz J., Rodriguez M. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 1996, 70:1729-1737.
90. Noseworthy J.H. Multiple sclerosis clinical trials: Old and new challenges. Semin. Neurol. 1998, 18:377-388.
91. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 2000, 343:938-952.
92. Ohara Y., Konno H., Iwasaki Y., Yamamoto T., Terunuma H., Suzuki H. Cytotropism of Theiler's murine encephalomyelitis viruses in oligodendrocyte-enriched cultures. Arch. Virol. 1990, 114:293-298.
93. Ohara Y., Stein S., Fu J.L., Stillman L., Klaman L., Roos R.P. Molecular cloning and sequence determination of the DA strain of Theiler's murine encephalomyelitis viruses. Virology 1988, 164:245-255.
94. Pappenheimer A.M. Pathology of infection with the JHM virus. J. Natl. Cancer Inst. 1958, 20:879-891.
95. Parra B., Hinton D.R., Marten N.W., Bergmann C.C., Lin M.T., Yang C.S., Stohlman S.A. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J. Immunol. 1999, 162:1641-1647.
96. Parra B., Lin M.T., Stohlman S.A., Bergmann C.C., Atkinson R., Hinton D.R. Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J. Virol. 2000, 74:2447-2450.
97. Patick A.K., Lindsley M.D., Rodriguez M. Differential pathogenesis between mouse strains resistant and susceptible to Theiler's virus-induced demyelination. Sem. Virol. 1990, 1:281-288.
98. Patick A.K., Pease L.R., David C.S., Rodriguez M. Major histocompatibility complex-conferred resistance to Theiler's virus-induced demyelinating disease is inherited as a dominant trait in B10 congenic mice. J. Virol. 1990, 64:5570-5576.
99. Pevear D.C., Borkowski J., Calenoff M., Oh C.K., Ostrowski B., Lipton H.L. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology 1988, 165:1-12.
100. Pevear D.C., Calenoff M., Rozhon E., Lipton H.L. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J. Virol. 1987, 61:1507-1516.
101. Pevear D.C., Luo M., Lipton H.L. Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: Clustering of amino acid difference identifies possible locations of immunogenic sites on the virion. Proc. Natl. Acad. Sci. USA 1988, 85:4496-4500.
102. Powell H.C., Lampert P.W. Oligodendrocytes and their myelin-plasma membrane connections in JHM mouse hepatitis virus encephalomyelitis. Lab Invest. 1975, 33(4):440-445.
103. Pullen L.C., Miller S.D., Dal Canto M.C., Kim B.S. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 1993, 23:2287-2293.
104. Reddi H.V., Lipton H.L. Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J. Virol. 2002, 76:8400-8407.
105. Rivera-Quinones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 1998, 4:187-193.
106. Rodriguez M. Virus-induced demyelination in mice: "dying back" of oligodendrocytes. Mayo Clin. Proc. 1985, 60:433-438.
107. Rodriguez M., David C.S. Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. J. Immunol. 1985, 135:2145-2148.
108. b mice deficient in beta 2-microglobulin. J. Immunol. 1993, 151:266-276.
109. Rodriguez M., Lafuse W.P., Leibowitz J., David C.S. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens). Neurology 1986, 36:964-970.
110. Rodriguez M., Leibowitz J., David C.S. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 1986, 163:620-631.
111. Rodriguez M., Leibowitz J.L., Lampert P.W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 1983, 13:426-433.
112. Rodriguez M., Nabozny G.H., Thiemann R.L., David C.S. Influence of deletion of T cell receptor V beta genes on the Theiler's virus model of multiple sclerosis. Autoimmunity 1994, 19:221-230.
113. Rodriguez M, Oleszak E., Leibowitz J. Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus. Crit Rev Immunol. 1987, 7:325-365.
114. Rodriguez M., Patick A.K., Pease L.R., David C.S. Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice. J. Immunol. 1992, 148:921-927.
115. Rodriguez M., Pavelko K.D., Njenga M.K., Logan W.C., Wettstein P.J. The balance between persistent virus infection and immune cells determines demyelination. J. Immunol. 1996, 157:5699-5709.
116. Rodriguez M., Roos R.P. Pathogenesis of early and late disease in mice infected with Theiler's virus. using intratypic recombinant GDVII/DA viruses. J. Virol. 1992, 66:217-225.
117. Rodriguez M., Siegel L.M., Hovanec-Burns D., Bologa L., Graves M.C. Theiler's virus-associated antigens on the surfaces of cultured glial cells. Virology 1988, 166:463-474.
118. Roos R.P., Wollmann R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 1984, 15:494-499.
119. Rosenthal A., Fujinami R.S., Lampert P.W. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest. 1986, 54:515-522.
120. Rossi C.P., Delcroix M., Huitinga I., McAllister A., van Rooijen N., Claassen E., Brahic M. Role of macrophages during Theiler's virus infection. J. Virol. 1997, 71:3336-3340.
121. Rouse B.T., Deshpande S. Viruses and autoimmunity: An affair but not a marriage contract. Rev. Med. Virol. 2002, 12:107-113.
122. Rueckert R.R. Picornaviridae: The Viruses and Their Replication. Fields Virology 1996, 609-654. Lippincott-Raven, London. 3rd ed. Fields, Knipe, Howley, Chanock, Melnick, Monath, Roizman, Strauss (Eds.).
123. Sapatino, B. V., Petrescu, A. D., Rosenbaum, B. A., Smith, R., 3rd, Piedrahita, J. A., and Welsh, C. J. Characteristics of cloned cerebrovascular endothelial cells following infection with Theiler's virus. II. Persistent infection. J. Neuroimmunol.62, 127-135.
124. Sarchielli P., Trequattrini A., Usai F., Murasecco D., Gallai V. Role of viruses in the etiopathogenesis of multiple sclerosis. Acta Neurol. (Napoli) 1993, 15:363-381.
125. Shaw-Jackson C., Michiels T. Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state. J. Virol. 1997, 71:8864-8867.
126. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313-1315.
127. Spencer P.S., Schaumburg H.H. Central-peripheral distal axonopathy: The pathology of dying-back polyneuropathies. Prog. Neuropathol. 1976, 3:253-295.
128. Stohlman S.A., Weiner L.P. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 1981, 31:38-44.
129. + T cells. J. Immunol. 1998, 160:2896-2904.
130. Stohlman S.A., Bergmann C.C., van der Veen R.C., Hinton D.R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J. Virol. 1995, 69:684-694.
131. Sun N., Grzybicki D., Castro R.F., Murphy S., Perlman S. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 1995, 213:482-493.
132. Takata H., Obuchi M., Yamamoto J., Odagiri T., Roos R.P., Iizuka H., Ohara Y. L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J. Virol. 1998, 72:4950-4955.
133. Toth K.S., Zhang C.X., Lipton H.L., Luo M. Crystallization and preliminary X-ray diffraction studies of Theiler's virus (GDVII strain). J. Mol. Biol. 1993, 231:1126-1129.
134. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
135. Trottier M., Kallio P., Wang W., Lipton H.L. High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J. Virol. 2001, 75:7420-7428.
136. Ure D.R., Rodriguez M. Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. FASEB J. 2002, 16:1260-1262.
137. Warrington A.E., Asakura K., Bieber A.J., Ciric B., Van Keulen V., Kaveri S.V., Kyle R.A., Pease L.R., Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 2000, 97:6820-6825.
138. Watanabe R., Wege H., ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 1983, 305:150-153.
139. Watanabe R., Wege H., ter Meulen V. Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats. Lab Invest. 1987, 57:375-384.
140. Encyclopedia of Virology 1995, Academic Press, Philadelphia. R.G. Webster, A. Granoff (Eds.).
141. Welsh C.J., Tonks P., Nash A.A., Blakemore W.F. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 1987, 68:1659-1667.
142. Wijburg O.L., Heemskerk M.H., Boog C.J., Van Rooijen N. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology 1997, 92:252-258.
143. Williams R.K., Jiang G.S., Holmes K.V. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 1991, 88:5533-5536.
144. + T cells. J. Virol. 1990, 64:4589-4592.
145. Williamson J.S., Sykes K.C., Stohlman S.A. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J. Neuroimmunol. 1991, 32:199-207.
146. Wroblewska Z., Gilden D.H., Wellish M., Rorke L.B., Warren K.G., Wolinsky J.S. Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab. Invest. 1977, 37:395-602.
147. Wu G.F., Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J. Virol. 1999, 73:8771-8780.
148. Xue S., Sun N., Van Rooijen N., Perlman S. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J. Virol. 1999, 73:6327-6334.
149. Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect. Dis. 2001, 1:29-37.
150. Zhang L., Senkowski A., Shim B., Roos R.P. Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J. Virol. 1993, 67:4404-4408.
151. Zheng L., Calenoff M.A., Dal Canto M.C. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J. Neuroimmunol. 2001, 118:256-267.
152. Zhou L., Lin X., Green T.J., Lipton H.L., Luo M. Role of sialyloligosaccharide binding in Theiler's virus persistence. J. Virol. 1997, 71:9701-9712.
153. Zhou L., Luo Y., Wu Y., Tsao J., Luo M. Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J. Virol. 2000, 74:1477-1485.